Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity [17]

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 2, 2008, Pages 257-258

  Bassukas, I D ^a   Hyphantis, T ^a   Gamvroulia, C ^a   Gaitanis, G ^a   Mavreas, V ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; LITHIUM CARBONATE; OLANZAPINE; RISPERIDONE; VENLAFAXINE;

ADULT; BIPOLAR DISORDER; CASE REPORT; COMORBIDITY; DEPRESSION; FEMALE; HUMAN; LETTER; MALE; MENTAL DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; PSYCHOSIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS;

EID: 38349004780     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02310.x     Document Type: Letter

References (6)

1. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology 2006;212: 123-127.
2. Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: A review. Australas J Dermatol 2004;45: 155-161.
3. Fortune DG, Richards HL, Kirby B et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003;139: 752-756.
4. Reich K, Nestle FO, Papp K et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. Lancet 2005;366: 1367-1374.
5. O'Brien SM, Scott LV, Dinan TG. Cytokines: Abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004;19: 397-403.
6. Brustolim D, Ribeiro-dos-Santos R, Kast RE, Altschuler EL, Soares MB. A new chapter opens in anti-inflammatory treatments: The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 2006;6: 903-907.